Ghent University Academic Bibliography

The synthesis and in vitro biological evaluation of novel fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosis

Davie Cappoen (UGent) , Eveline Torfs, Tamara Meiresonne (UGent) , Pieter Claes (UGent) , Elena Semina (UGent) , Francis Holvoet, Maíra Bidart de Macedo, Freya Cools, Tatiana Piller, An Matheeussen, et al.

(2019) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 181.

Add to list

Novel potentiators for vancomycin in the treatment of biofilm-related MRSA infections via a mix and match approach

Arno Vermote (UGent) , Gilles Brackman (UGent) , Martijn Risseeuw (UGent) , Davie Cappoen (UGent) , Paul Cos, Tom Coenye (UGent) and Serge Van Calenbergh (UGent)

(2017) ACS MEDICINAL CHEMISTRY LETTERS. 8(1). p.38-42

Add to list

Monoclonal antibody binding to the macrophage-specific receptor sialoadhesin alters the phagocytic properties of human and mouse macrophages

Marjorie De Schryver, Davie Cappoen, Dirk Elewaut (UGent) , Hans Nauwynck (UGent) , Louis Maes, Guy Caljon, Paul Cos and Peter L Delputte

(2017) CELLULAR IMMUNOLOGY. 312. p.51-60

Add to list

Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia

Bieke Vanhoutte, Davie Cappoen, Bidart de Macedo Maira, Freya Cools, Eveline Torfs, Tom Coenye (UGent) , Wim Martinet, Guy Caljon, Louis Maes, Peter Delputte, et al.

(2017) JOURNAL OF MICROBIOLOGICAL METHODS. 139. p.181-188

Add to list

Journal Article
A1
open access

Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models

Freija Van den Driessche (UGent) , Bieke Vanhoutte, Gilles Brackman (UGent) , Aurélie Crabbé (UGent) , Petra Rigole (UGent) , Jurgen Vercruysse, Glenn Verstraete (UGent) , Davie Cappoen, Chris Vervaet (UGent) , Paul Cos, et al.

(2017) PLOS ONE. 12(3).

Add to list

Journal Article
A1
open access

Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents

Lijun Song (UGent) , Martijn Risseeuw (UGent) , Matheus Froeyen, Izet Karalic (UGent) , Jan Goeman (UGent) , Davie Cappoen, Johan Van der Eycken (UGent) , Paul Cos, Hélène Munier-Lehmann and Serge Van Calenbergh (UGent)

(2016) BIOORGANIC & MEDICINAL CHEMISTRY. 24(21). p.5172-5182

Add to list

PhD Thesis

Discovery and biological evaluation of novel heterocyclic antitubercular drug candidates

Davie Cappoen (UGent)

(2014)

Add to list

1,2,3,4,8,9,10,11-Octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis

Davie Cappoen (UGent) , Pieter Claes (UGent) , Jan Jacobs (UGent) , Roel Anthonissen, Vanessa Mathys, Luc Verschaeve, Kris Huygen and Norbert De Kimpe (UGent)

(2014) JOURNAL OF MEDICINAL CHEMISTRY. 57(7). p.2895-2907

Add to list

Synthesis and antimycobacterial activity of analogues of the bioactive natural products sampangine and cleistopholine

Pieter Claes (UGent) , Davie Cappoen, Blaise Mbala-Mavinga, Jan Jacobs (UGent) , Birgit Mertens, Vanessa Mathys, Luc Verschaeve, Kris Huygen and Norbert De Kimpe (UGent)

(2013) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 67. p.98-110

Add to list

Straightforward palladium-mediated synthesis and biological evaluation of benzo[j]phenanthridine-7,12-diones as anti-tuberculosis agents

Davie Cappoen (UGent) , Jan Jacobs (UGent) , Tuyen Nguyen Van, Sven Claessens, Gaston Diels, Roel Anthonissen, Thorbjorg Einarsdottir, Maryse Fauville, Luc Verschaeve, Kris Huygen, et al.

(2012) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 48. p.57-68

Academic Bibliography

The synthesis and in vitro biological evaluation of novel fluorinated tetrahydrobenzo[j]phenanthridine-7,12-diones against Mycobacterium tuberculosis

Novel potentiators for vancomycin in the treatment of biofilm-related MRSA infections via a mix and match approach

Monoclonal antibody binding to the macrophage-specific receptor sialoadhesin alters the phagocytic properties of human and mouse macrophages

Optimization and characterization of a murine lung infection model for the evaluation of novel therapeutics against Burkholderia cenocepacia

Evaluation of combination therapy for Burkholderia cenocepacia lung infection in different in vitro and in vivo models

Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents

Discovery and biological evaluation of novel heterocyclic antitubercular drug candidates

1,2,3,4,8,9,10,11-Octahydrobenzo[j]phenanthridine-7,12-diones as new leads against Mycobacterium tuberculosis

Synthesis and antimycobacterial activity of analogues of the bioactive natural products sampangine and cleistopholine

Straightforward palladium-mediated synthesis and biological evaluation of benzo[j]phenanthridine-7,12-diones as anti-tuberculosis agents

Contents

Support

Contact